AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 112.50
-1.00 (-0.88%)
Oct 31, 2025, 2:35 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 9.58 billion as of October 31, 2025. Its market cap has increased by 94.86% in one year.
Market Cap
9.58B
Enterprise Value
8.28B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
112.50
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 9.58B, an increase of 87.91%. That is a compound annual growth rate of 31.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 9.58B | 126.73% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |